Wednesday 22 July 2026

One To Watch

Chiasma

Company Overview

Want to Update your Company's Profile?


Latest Chiasma News

The new science and business of oral biologics
6 January 2026
Amryt Pharma buying Chiasma, to create rare diseases powerhouse
6 May 2021
Positive Phase III data for Mycapssa
23 March 2021
Chiasma set for EMA filing based on acromegaly data
18 November 2020
More Chiasma news >


Today's issue

BridgeBio clears key FDA milestone for rare calcium disorder therapy encaleret
Pharmaceutical
BridgeBio clears key FDA milestone for rare calcium disorder therapy encaleret
22 July 2026
Biotechnology
Biogen, Pfizer vet joins Formation Bio as CSO
22 July 2026
Biotechnology
ARScience advances manufacturing plans for low-dose IL-2 program
22 July 2026
Generics
Indian drugmakers slide as USA plans 200% generic tariff
22 July 2026
Pharmaceutical
Sanofi reshapes executive team as it prepares next phase of strategy
22 July 2026
Pharmaceutical
Grünenthal strengthens its genetic medicine capabilities
22 July 2026
Generics
Lonza delivers strong 1st-half 2026 performance
22 July 2026




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze